Yongqian Shu

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 04, 2023
Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop.

Tingting Xu, Mengyan Xie, Xinming Jing

|Apr 29, 2022
Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer.

Huning Jiang, Jiahua Cui, Hao Chu

|Oct 19, 2021
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study.

Zhi Peng, Tianshu Liu, Jia Wei

|Sep 10, 2021
Crosstalk between Environmental Inflammatory Stimuli and Non-Coding RNA in Cancer Occurrence and Development.

Tingting Xu, Mengyan Xie, Xinming Jing

|Aug 02, 2021
The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells.

Lijun Wang, Luqun Tang, Chengyun Yao

Pageof 1

Frequent Collaborators

1 joint publications

Lijun Wang

1 joint publications

Luqun Tang

1 joint publications

Chengyun Yao

1 joint publications

Yi Ba